Recipharm’s customer, Meda, is terminating its manufacturing and supply agreement for its penicillin products as of December 31, 2015, with plans to offshore production. This business accounts for approximately 2% of Recipharm’s current sales and will impact its 60 employees in Strängnäs, likely leading to a reduction in staff, and potentially closure of the site. Financially, the termination will have a positive impact on Recipharm’s profitability from 2016.   The Meda business in Strängnäs gen...